Phase 2 is due in March.A note that the results of phase 1 was...

Phase 2 is due in March.

A note that the results of phase 1 was successful demonstrating the benefits of CBD for a full plant in a medical sense that is independently verified 

As this was a world first, the company kept the results private due to competitive and commercial sensitivity at this stage of clinical investigations.

I also note that BDA has the same commercial and business operating model as AGH ( import, export licenses) in addition to our high value nutraceutical business yet we are value a factor of 2.5 times less than AGH. AGH has been really aggresive in growing so BDA must make a move rapidly to build awareness and reputation domestically and globally